@conference{532c756d32d7490680c3038276afeffd,
title = "The spectrum of activating EGFR mutations from cell-free DNA (cfDNA) in large pancreatic cancer cohort.",
author = "Price, \{Kristin Sedgwick\} and Kiedrowski, \{Lesli Ann\} and \{De Zarraga\}, \{Fernando I.\} and Mike Cusnir and Lanman, \{Richard B.\} and Nagy, \{Rebecca J\} and deZarraga, \{Fernando I\}",
note = "237 Background: Metastatic pancreatic cancer (mPC) is one of the deadliest cancers with a < 10\% 5-year survival rate. Poor prognosis is well established with lack of response to or rapid progression on existing chemotherapy options. Targeted therapies, like EGFR-TKIs, have been shown to increase survival in other solid tumors like NSCLC with certain oncogenic drivers.; 2019 Gastrointestinal Cancers Symposium ; Conference date: 01-01-2019",
year = "2019",
doi = "10.1200/JCO.2019.37.4\_suppl.237",
language = "American English",
}